ABSTRACT
To develop a new kind of famotidine-resin microcapsule for gastric adhesion sustained release by screening out suitable excipients and designing reasonable prescriptions to improve patient drug activities to achieve the expected therapeutic effect. The famotidine drug resin was prepared using the water bath method with carbomer 934 used as coating material. Microcapsules were prepared using the emulsified solvent coating method and appropriate excipients were used to prepare famotidine sustained release suspension. Pharmacokinetics of the developed microcapsules were studied in the gastrointestinal tract of rats. The self-made sustained-release suspension of famotidine hydrochloride effectively reduced the blood concentration and prolonged the action time. The relative bioavailability of the self-made suspension of the famotidine hydrochloride to the commercially available famotidine hydrochloride was 146.44%, with an average retention time of about 5h longer, which indicated that the new suspension had acceptable adhesion properties. The findings showed that the newly developed famotidine-resin microcapsule increased the bioavailability of the drug with a significant sustained-release property.
Subject(s)
Biological Availability , Delayed-Action Preparations , Famotidine , Famotidine/pharmacokinetics , Famotidine/administration & dosage , Famotidine/chemistry , Famotidine/pharmacology , Animals , Rats , Male , Excipients/chemistry , Suspensions , Capsules , Drug Liberation , Acrylic Resins/chemistry , Histamine H2 Antagonists/pharmacokinetics , Histamine H2 Antagonists/administration & dosage , Histamine H2 Antagonists/pharmacology , Histamine H2 Antagonists/chemistry , Adhesiveness , Drug Compounding , AcrylatesABSTRACT
In this study, a new gastro-floating sustained-release tablet (GFT) with a combination of Etoricoxib (ET) and Famotidine (FM) was successfully developed. GFTs were prepared by using a combination of hydrophilic swellable natural/semi-synthetic polymers as a controlled-release layer. Through a 24 full factorial statistical experimental design, the effects of formulation factors on the release of GFTs were conducted. The ideal floating tablet (FT) comprised konjac-gum (150 mg), guar-gum (26.57 mg), xanthan-gum (54.17 mg), and HPMC-K15-M (69.25 mg). The ideal FT exhibited a high swelling index (SI) (297.7%) and rapid FLT (around 50 s) in 0.1 N HCl as well as controlled release of ET (22.43% in 1 h and 77.47% in 8 h) and FM (24.89% in 1 h and 93.82% in 8 h) with the absence of any drug-excipient interactions. The AUC0â¼72 (ng h/mL) of ET and FM in the GFTs were approximately double-fold of the market, respectively. The relative bioavailability was (207.48 ± 12.02% and 208.51 ± 13.11%) compared with commercial tablets. The X-ray imaging showed a promising buoyancy ability for approximately 8 h. These findings revealed the successful preparation of the sustained-release floating tablet with improved dual drug delivery.
Subject(s)
Delayed-Action Preparations , Drug Liberation , Etoricoxib , Famotidine , Tablets , Famotidine/administration & dosage , Famotidine/pharmacokinetics , Famotidine/chemistry , Etoricoxib/administration & dosage , Etoricoxib/pharmacokinetics , Etoricoxib/chemistry , Animals , Male , Rabbits , Excipients/chemistry , Biological AvailabilityABSTRACT
Famotidine (FMT) is an orally administered histamine H2-receptor blocker with limited bioavailability since it exhibits low solubility and low permeability. In addition, the recent withdrawal of ranitidine from the market, makes famotidine an interesting candidate to obtain solid forms with improved pharmacokinetic performance. In this work, crystal engineering concepts and the co-amorphous formation strategy were applied to obtain two novel solids. Crystalline famotidine malate (FMT-MT) and a vitreous phase (FMT-MTa) were prepared by solvent evaporation and mechanochemical synthesis, respectively. FMT-MT (monoclinic, S.G. P21/n) crystallizes with one FMT and one co-former molecules in the asymmetric unit forming a (R228) structural motif. FMT-MT resulted in a salt by proton transfer from one malic carboxylic group to the guanidine moiety of FMT. The three-dimensional packing is described as undulating layers of alternated FMT+ and MT- running along the a direction. FMT-MTa shows the inherent features of amorphous phases according to powder X-ray diffraction and DSC analysis. The higher physical stability was found for amorphous samples maintained at 4 °C up to 60 days. The solubility assays in water, indicate that FMT-MT and FMT-MTa are 2.02 and 2.68-fold more soluble than the marketed polymorph, whereas similar values were obtained in simulated gastric fluid.
Subject(s)
Famotidine , Malates , Famotidine/chemistry , Solubility , Histamine H2 Antagonists , X-Ray Diffraction , Calorimetry, Differential Scanning , Drug Stability , Spectroscopy, Fourier Transform InfraredABSTRACT
In this study, new stimuli - responsive hybrid hydrogels were achieved via succinylated cellulose nanocrystals (Su-CNC). The innovation was concerned with the inclusion of Su-CNC, at different degree of substitution (DS), into hydrogel network to render it pH and thermo-responsive characters through free radical polymerization reaction with poly(N-isopropylacrylamide) (PNIPAm). The prepared hydrogel was also examined for the in vitro release of Famotidine at different pH values. As clearly evident from the results, all the hydrogels prepared with different DS of Su-CNC, which were nominated as Su-CNC / PNIPAm (1-3), showed a high response to temperature change since their swelling behavior and hydrophilicity were decreased at 35 °C and upwards. This led to the more hydrophobicity character and thus the hydrogel shrinkage occurred. On the other hand, at pH 6, the hydrogels exhibited a significant Equilibrium Swelling Ratio (ESR) attaining 18.1, 17.3 and 16.8 (g/g) for Su-CNC / PNIPAm (1-3), respectively. However, Su-CNC / PNIPAm 2 hydrogel showed a significant response to the pH change from 8 to 2 which was advised to be selected as a potential pH responsive hydrogel for the in vitro Famotidine release.
Subject(s)
Anti-Ulcer Agents/chemistry , Cellulose/chemistry , Famotidine/chemistry , Hydrogels/chemistry , Nanoparticles/chemistry , Temperature , Drug Carriers/chemistry , Drug Liberation , Hydrogen-Ion Concentration , Hydrophobic and Hydrophilic Interactions , Molecular StructureABSTRACT
Indomethacin is one of the nonsteroidal anti-inflammatory drugs (NSAIDs) that are widely prescribed drug for pain and inflammation. However, its notoriety of causing gastrointestinal effect, low water solubility, and its short half-life would affect patient compliance and its oral absorption and accordingly justify the need to develop a formula with a controlled and sustained release manner in combination with anti-ulcer drugs. Herein, we synthesized indomethacin-paracetamol co-drug loaded in nanoemulsion and encapsulated in famotiditine loaded polycaprolactone (PCL) nanoparticles. The synthesis of the co-drug was achieved by the formation of a hydrolyzable ester between the indomethacin and paracetamol. The synthesized co-drug was preloading in nanoemulsion (Co-NE), which encapsulated into famotidine PCL nanoparticles utilizing the nanoprecipitation approach. The developed nanosystem showed hydrodynamic size less than 200 nm and the zeta potential value above -30 mV. TEM images confirmed the morphological structure of the formed nanoemulsion and the loaded PCL nanoparticles. Stability studies revealed that the developed nanosystem was stable at different temperatures and pHs over 1 month. Moreover, improvement of the solubilities of these three drugs leading to have a controlled-release multicomponent system of both co-drug and famotidine over 3 days. This multicomponent nanoparticle might be a potential platform to overcome the obstacles of NSAIDs, synergize drugs with different mechanisms of actions by co-encapsulating a small-sized nanoemulsion into PCL nanoparticles for reaching the goal of effective anti-inflammatory therapy.
Subject(s)
Acetaminophen/chemistry , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Famotidine/chemistry , Histamine H2 Antagonists/chemistry , Indomethacin/chemistry , Nanoparticles/chemistry , Drug Compounding , Emulsions , Fibroblasts/drug effects , HeLa Cells , Humans , Molecular StructureABSTRACT
The competence of hydrophilic interaction (HILIC) and reversed phase liquid chromatography (RPLC) modes, employing two new stationary phases: triazole- and pentabromobenzyl-bonded silica (PBr), respectively, was inspected for separation of two polar basic analytes: famotidine (FAM) and its acidic degradant famotidone (FON). Comparison of the chromatographic efficiency, greenness, and economy aspects showed that the RPLC is superior to the HILIC. Hence, the RPLC method was adopted and validated adhering to the FDA guidelines showing excellent linearity for FAM (1.0-20.0⯵g/mL) with a detection limit of 0.14⯵g/mL. The method was applied to study the behavior of FAM in simulated gastric juice (SGJ), where it exhibited rapid degradation yielding FON. This degradation pathway is a probable major reason for the poor bioavailability of FAM. The kinetic study of the gastric degradation of FAM in SGJ demonstrated pseudo-first order reaction with a rate constant of 8.1â¯×â¯10-3â¯min-1. Moreover, FAM degradation has been proven to be pH-dependent and catalyzed by the gastric juice components. Hence, in situ buffered dosage form is recommended to overcome or decrease this problem. Molecular docking study shows that FON is missing a crucial stabilizing interaction with the key amino acid Asp98 causing a reduced activity at hH2R receptor relative to FAM. Moreover, ADMET properties prediction revealed some differences in the toxicity, pharmacokinetics, metabolism, and solubility profiles of FAM and FON.
Subject(s)
Chromatography, Reverse-Phase/methods , Famotidine/analysis , Gastric Juice/metabolism , Famotidine/chemistry , Famotidine/pharmacokinetics , Humans , Hydrogen-Ion Concentration , Hydrophobic and Hydrophilic Interactions , Limit of Detection , Molecular Docking Simulation , Silicon Dioxide/chemistry , Solubility , Triazoles/chemistryABSTRACT
We used a combination of density functional theory (DFT) calculations and the implicit quantization of the acidic N-H and O-H bonds to assess the effect of deuteration on the binding of agonists (2-methylhistamine and 4-methylhistamine) and antagonists (cimetidine and famotidine) to the histamine H2 receptor. The results show that deuteration significantly increases the affinity for 4-methylhistamine and reduces it for 2-methylhistamine, while leaving it unchanged for both antagonists, which is found in excellent agreement with experiments. The revealed trends are interpreted in the light of the altered strength of the hydrogen bonding upon deuteration, known as the Ubbelohde effect, which affects ligand interactions with both active sites residues and solvent molecules preceding the binding, thus providing strong evidence for the relevance of hydrogen bonding for this process. In addition, computations further underline an important role of the Tyr250 residue for the binding. The obtained insight is relevant for the therapy in the context of (per)deuterated drugs that are expected to enter therapeutic practice in the near future, while this approach may contribute towards understanding receptor activation and its discrimination between agonists and antagonists.
Subject(s)
Deuterium/chemistry , Hydrogen Bonding , Ligands , Receptors, Histamine H2/chemistry , Binding Sites , Cimetidine/chemistry , Density Functional Theory , Drug Design , Famotidine/chemistry , Humans , Methylhistamines/chemistry , Normal Distribution , Protein Binding , Protons , Water/chemistryABSTRACT
Famotidine (FM) is considered among the first-line therapy for treatment of gastric ulcers; however, its poor aqueous solubility resulted in low bioavailability and limited therapeutic efficacy. Therefore, fast disintegrating tablet (FDT) incorporating FM solid dispersion was developed in a combined formulation approach for efficient treatment of ulcers. Within the investigated polymers, solid dispersions were prepared using the novel copolymer, Soluplus® (SP) by kneading and freeze-drying techniques at various FM:SP ratios. FM solid dispersion prepared at 1:10 ratio using freeze drying (FM-SP10) manifested the highest saturation solubility, having smooth porous surface with the complete conversion of FM to the amorphous form. FDTs of FM-SP10 was produced by direct compression using three ready-to-use excipients; F-melt, Pearlitol Flash, and Fujicalin. All tablets showed adequate thickness, diameter, weight variation, drug content, and friability (<1%). Fujicalin-FDTs (FM-FDT-FU) exhibited the shortest disintegration time with almost complete dissolution of the drug (>95%) within 30 min. It also revealed remarkable antiulcerogenic effect on ethanol induced gastric ulcers in terms of ulcer and protection indices compared to the market product. Pretreated rats with FM-FDT-FU demonstrated normal gastric area with the absence of edema and leucocytes infiltration, supported by the histological examination. FM-FDT-FU administration protected the stomach from oxidative damage and severe inflammatory response via the significant increase of glutathione level and the decreased levels of nitric oxide, interleukin and cyclooxygenase. Thus, the present study provides a promising dosage form of FM characterized by superior antiulcerogenic potential with desired tableting properties.
Subject(s)
Famotidine/chemistry , Famotidine/pharmacology , Polyethylene Glycols/chemistry , Polyvinyls/chemistry , Solubility/drug effects , Stomach Ulcer/drug therapy , Tablets/chemistry , Tablets/pharmacology , Animals , Chemistry, Pharmaceutical/methods , Drug Compounding/methods , Excipients/chemistry , Inflammation/diet therapy , Male , Polymers/chemistry , Rats , Rats, Wistar , Stomach/drug effectsABSTRACT
The present work demonstrates the utility of temperature controlled set up with pressurized headspace oxygen as an approach to effectively reduce the time required for solid-state drug-excipient compatibility study. To illustrate the utility, the incompatibility of polyethylene glycol (PEG) and polyethylene oxide (PEO) with Famotidine (Fam) was shown. Owing to thermal and oxidative stress, polyethylene ether moieties of PEG generated reactive impurities, resulting in the degradation of Fam. The chemical degradation was evaluated via liquid chromatography. Around 20% of degradation was observed in the pressurized oxygen set up, whereas, no degradation was found in the absence of oxidative stress. On increasing the excipient fraction, the Fam degradation increased proportionally. Formation of aldehydes and free radicals from excipients were proposed as the precursors for Fam degradation. The generation of aldehydes and free radicals was confirmed by infrared and Electron Spin Resonance (ESR) spectroscopic analysis, respectively. Overall, the present study demonstrated the utility of pressurized oxygen set up as a rapid and routine tool for studying drug-excipient incompatibility at temperatures relevant drug-product manufacture.
Subject(s)
Drug Incompatibility , Excipients/chemistry , Famotidine/chemistry , Polyethylene Glycols/chemistry , Chemistry, Pharmaceutical/methods , Chromatography, Liquid/methods , Feasibility Studies , Oxidative Stress , Oxygen/chemistry , TemperatureABSTRACT
Ag/ZnO nanocomposites are successfully synthesized at different Ag contents through simple, effective, high yield and low-cost mechanochemical combustion technique, with the addition of silver acetate to zinc acetate and oxalic acid mixture. The synthesized materials are characterized by X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), scanning electron spectroscopy (SEM), BET surface area analysis, UV - visible diffuse reflectance spectroscopy (UV - DRS) and photoluminescence spectroscopy (PL). It is shown that the prepared nanocomposites are composed of metallic Ag0 and wurtzite ZnO. The photocatalytic performance of different composites is evaluated by the degradation of Famotidine (FMT) under UV irradiation. The results indicate it that the maximum photodegradation rate is obtained with 6 wt% metallic Ag-decorated ZnO, and it is 2.1 times better than that obtained with pure ZnO. The photocatalytic degradation of FMT with Ag/ZnO is affected by various parameters such as calcination temperature and time, doping concentrations and reusability. The Ag/ZnO demonstrates higher activity due to the reduction of electron - hole recombination and Ag0 metal catalyst. The possible photocatalytic degradation mechanism of FMT with Ag/ZnO is estimated from the scavenger test.
Subject(s)
Acetates/chemistry , Famotidine/chemistry , Silver Compounds/chemistry , Zinc Oxide/chemistry , Catalysis , Nanocomposites/chemistry , Oxalic Acid/chemistry , Photolysis , Temperature , Ultraviolet RaysABSTRACT
The usage of Fourier transform infrared spectroscopy, near infrared spectroscopy, differential scanning calorimetry and microscopy is presented in this work focused on the exploration of the effect of CD on the physical stability of famotidine (FAM). The most significant information was achieved by analysis of the second derivatives of near infrared (NIR) spectra recorded. Changes in the shape of spectra derivatives allow to observe the improvement of physical stability of FAM with the usage of various supramolecular systems based on ß-cyclodextrin (CD) derivatives. The comparison was performed with the usage of maltodextrin in FAM mixtures. We found out that ß-cyclodextrin derivatives in the form of physical mixture and inclusion complexes successfully increased the physical stability of famotidine in solid state while maltodextrin does not show positive effect in imparting physical stability to famotidine.
Subject(s)
Famotidine/chemistry , Histamine H2 Antagonists/chemistry , beta-Cyclodextrins/chemistry , Calorimetry, Differential Scanning , Drug Stability , Excipients/chemistry , Spectroscopy, Fourier Transform Infrared , Spectroscopy, Near-InfraredABSTRACT
One of the relatively advance 3rd generation cephalosporins, cefpodoxime proxetil, is being used all-around. Generally, these are used for the cure of infections allied to urinary and respiratory tract. These cephalosporins have showed a remarkable in vitro activity against many strains of bacteria which are resistant to other orally used active medicinal substances. It is the first oral 3rd generation cephalosporin to be used in the cure of skin infections. The practice of H2 receptor antagonists, concerning lots of treatments recommended in patients with different types of ulcers and allergic urticarial condition, is raising hazards of unwanted secondary outcomes and drug interactions. Learning of in-vitro interaction between cefpodoxime poxetil and H2 blockers (Ranitidine, Famotidine and Cimetidine) were examined applying UV/Visible spectrophotometry and Infrared spectrometry. In the existence of H2 receptor blockers, the cefpodoxime proxetil availability was found to be decreased in vitro only under specific conditions. Furthermore, complexes of Cefpodoxime proxetil-H2 receptor antagonists were manufactured approving the interaction of these drugs. Finally, the above mentioned spectrophotometric techniques were employed to examine the complexes formed (Cefpodoxime proxetil-cimetidine, cefpodoxime proxetil-famotidine and cefpodoxime proxetil-ranitidine).
Subject(s)
Ceftizoxime/analogs & derivatives , Histamine H2 Antagonists/chemistry , Histamine H2 Antagonists/pharmacokinetics , Ceftizoxime/chemistry , Ceftizoxime/pharmacokinetics , Cimetidine/chemistry , Cimetidine/pharmacology , Drug Interactions , Famotidine/chemistry , Famotidine/pharmacokinetics , Ranitidine/chemistry , Ranitidine/pharmacokinetics , Spectrophotometry, Infrared , Spectrophotometry, Ultraviolet , Cefpodoxime ProxetilABSTRACT
Famotidine, an antiulcer drug belonging to the H2 antagonists class of pharmacological agents, was recently shown to potently inhibit human (h) and bacterial carbonic anhydrases (CAs, EC 4.2.1.1). We investigated the inhibitory effects of famotidine against all classes of CAs from the pathogenic bacteria Vibrio cholerae, Burkholderia pseudomallei and Mycobacterium tuberculosis Rv3273 ß-CA, as well as the CAs from the nonpathogenic bacteria/cyanobacteria Sulfurihydrogenibium yellowstonensis, S. azorense, Pseudoalteromonas haloplanktis, Colwellia psychrerythraea and Nostoc commune. The δ- and ζ-CAs from the diatom Thalassiosira weissflogii, the fungal enzymes from Cryptococcus neoformans, Candida glabrata and Malassezia globosa, as well as the protozoan enzymes from Trypanosoma cruzi and Plasmodium falciparum, were also investigated. Anopheles gambiae ß-CA was also investigated. All these enzymes were effectively inhibited by famotidine, with affinities between the low nanomolar to the micromolar range. The best inhibition was observed against C. glabrata ß-CA and TweCAζ, with KIs ranging between 13.6 and 22.1 nM.
Subject(s)
Carbonic Anhydrase Inhibitors/pharmacology , Carbonic Anhydrases/metabolism , Famotidine/pharmacology , Bacteria/enzymology , Carbonic Anhydrase Inhibitors/chemical synthesis , Carbonic Anhydrase Inhibitors/chemistry , Chlorophyta/enzymology , Diatoms/enzymology , Famotidine/chemical synthesis , Famotidine/chemistry , Fungi/enzymology , Humans , Molecular Structure , Plasmodium falciparum/enzymology , Trypanosoma cruzi/enzymologyABSTRACT
Our work aimed at evaluating the use of permeability glycoprotein (P-gp) inhibiting nanoparticles (NPs) as a part of a suitable oral solid dosage to improve bioavailability. Famotidine (Pepcid®), a stomach acid production inhibitor, was used as a drug model to test our hypothesis. Famotidine-loaded NPs were prepared by solvent emulsion evaporation using PEG grafted on a polylactide acid (PLA) polymer backbone (PLA-g-PEG), with a 5% molar ratio of PEG versus lactic acid monomer and PEG of either 750 or 2000 Da molecular weight. Tablet formulation was composed of 40% Famotidine-loaded NPs, 52.5% microcrystalline cellulose as filler, 7% pre-gelatinized starch as binder/disintegrant, and 0.5% magnesium stearate as lubricant. Tablets containing 1.6 mg of Famotidine were prepared at an average weight of 500 mg, thickness of 6.2-6.5 mm, hardness of 5-8 kp, and disintegration time of <1 min. Our results suggest that Famotidine-loaded NPs using grafted PEG-g-PLA polymers can be formulated as an oral solid dosage form while effectively inhibiting P-gp mediated Famotidine efflux, irrespective of PEG molecular weights. This could therefore represent an attractive formulation alternative to enhance oral permeability and bioavailability of drugs that are P-gp substrates.
Subject(s)
Famotidine/chemistry , Glycoproteins/chemistry , Nanoparticles/chemistry , Polyesters/chemistry , Polyethylene Glycols/chemistry , Polymers/chemistry , Tablets/chemistry , Biological Availability , Chemistry, Pharmaceutical/methods , Drug Carriers/chemistry , Excipients/chemistry , Particle Size , Permeability , Starch/chemistryABSTRACT
The landscape of thin films is continuously evolving as an attractive self-administration mean to drive patient compliance. This work reports incorporation of drugs into various polymeric compositions using spin coating technology to screen amorphous solid dispersion film formation for buccal applications. Polarized light microscopy and differential scanning calorimetry were used for characterization. Physical stability was assessed after films storage at 0% RH/25°C for 6 months. Chlorpheniramine maleate, theophylline, and famotidine were used as model drugs and mixed with Opadry amb II® or Kollicoat IR®. Acryl-EZE II® or Zein was also used as surface (design I) or surface and base polymers (design II). Of all the drug-Opadry combinations, only chlorpheniramine was amorphously dispersed up to 25% (w/w). In contrast, Kollicoat IR® resulted in amorphous dispersions of all the tested drugs, suggesting that it has a better solubilization capacity. Drugs prepared in design II achieved higher in vitro release compared to respective design I, indicating that lower content of Acryl-EZE II® or Zein can decrease drug release over 3 h. It has been also revealed that Zein could improve physical stability of the aged theophylline solid-dispersed films. Release kinetics of model drugs were satisfactory when described by first-order kinetics, facilitated through anomalous transport of both diffusion and polymer swelling.
Subject(s)
Drug Delivery Systems/methods , Polymers/chemistry , Administration, Buccal , Bronchodilator Agents/administration & dosage , Bronchodilator Agents/chemistry , Chlorpheniramine/administration & dosage , Chlorpheniramine/chemistry , Drug Liberation , Famotidine/administration & dosage , Famotidine/chemistry , Histamine H1 Antagonists/administration & dosage , Histamine H1 Antagonists/chemistry , Histamine H2 Antagonists/administration & dosage , Histamine H2 Antagonists/chemistry , Humans , Polyvinyls/chemistry , Solubility , Theophylline/administration & dosage , Theophylline/chemistry , Zein/chemistryABSTRACT
Famotidine (FMT) and ibuprofen (IBU) were used as model drugs to obtain coamorphous systems, where the guanidine moiety of the antacid and the carboxylic group of the nonsteroidal anti-inflammatory drug could potentially participate in H-bonds leading to a given structural motif. The systems were prepared in 3:7, 1:1, and 7:3 FMT and IBU molar ratios, respectively. The latter two became amorphous after 180 min of comilling. FMT-IBU (1:1) exhibited a higher physical stability in assays at 4, 25, and 40 °C up to 60 days. Fourier transform infrared spectroscopy accounted for important modifications in the vibrational behavior of those functional groups, allowing us to ascribe the skill of 1:1 FMT-IBU for remaining amorphous to equimolar interactions between both components. Density functional theory calculations followed by quantum theory of atoms in molecules analysis were then conducted to support the presence of the expected FMT-IBU heterodimer with consequent formation of a R228 structural motif. The electron density (ρ) and its Laplacian (∇2ρ) values suggested a high strength of the specific intermolecular interactions. Molecular dynamics simulations to build an amorphous assembly, followed by radial distribution function analysis on the modeled phase were further employed. The results demonstrate that it is a feasible rational design of a coamorphous system, satisfactorily stabilized by molecular-level interactions leading to the expected motif.
Subject(s)
Antacids/chemistry , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Drug Compounding , Famotidine/chemistry , Ibuprofen/chemistry , Density Functional Theory , Drug Design , Hydrogen Bonding , Models, Chemical , Molecular Dynamics Simulation , Molecular Structure , Spectroscopy, Fourier Transform InfraredABSTRACT
Schizophrenia (SCZ) is one of the brain disorders which affects the thinking and behavioral skills of patients. This disorder comes along with an overproduction of kynurenic acid in the cerebrospinal fluid and the prefrontal cortex of SCZ patients. In this study, marine bacterial compounds were screened for their suitability as antagonists against human kynurenine aminotransferase (hKAT-1) which causes the synthesis of kynurenic acid downstream which ultimately causes the SCZ disorder according to the kynurenic hypothesis of SCZ. The marine actinobacterial compound bonactin shows more promising results than other tested marine compounds such as the histamine H2 blocker famotidine and indole-3-acetic acid (IAC) from docking and in silico toxicological studies carried out here. The obtained results of the Grid-based Ligand Docking with Energetics (Glide) scores of extra-precision (XP) Glide against the target protein hKAT-1 on IAC, famotidine, and bonactin were - 6.581, - 6.500 and - 7.730 kcal/mol where Glide energies were - 29.84, - 28.391, and - 47.565 kcal/mol, respectively. Bonactin is known as an antibacterial and antifungal compound being extracted from a marine Streptomyces sp. Comparing tested compounds against the drug target hKAT-1, bonactin alone showed the best Glide score and Glide energy on the target protein hKAT-1.
Subject(s)
Antipsychotic Agents/chemistry , Antipsychotic Agents/pharmacology , Schizophrenia/prevention & control , Streptomyces/chemistry , Transaminases/antagonists & inhibitors , Binding Sites , Computational Biology , Drug Interactions , Famotidine/chemistry , Famotidine/pharmacology , Furans/chemistry , Furans/pharmacology , Humans , Indoleacetic Acids/chemistry , Indoleacetic Acids/pharmacology , Kynurenic Acid/metabolism , Protein BindingABSTRACT
ãIn recent years, self-medication has started to receive more attention in Japan owing to increasing medical costs and health awareness among people. One of the main roles of pharmacists in self-medication is to provide appropriate information regarding OTC drugs. However, pharmacists promoting the proper use of OTC drugs have little information on their formulation properties. In this study, we performed dissolution tests on both OTC drugs and ethical drug (ED) containing famotidine, and evaluated the differences in their dissolution profiles. Marked differences in dissolution profiles of OTC drugs were observed in test solutions at pH 1.2, 4.0, and 6.8 and in water. To evaluate the differences quantitatively, we calculated the lag time and dissolution rate constant from the dissolution profiles. Significant differences in lag times and dissolution rate constants between some OTC drugs and ED were observed. We also used similarity factor (f2), to quantify the similarity between dissolution profiles of OTC drugs and ED. f2 values less than 42 were observed in some OTC drugs, suggesting that these differences might influence absorption in vivo resulting in differences in their onset time and efficacy. The findings of this study will provide useful information for the promotion of proper use of OTC drugs.
Subject(s)
Chemical Phenomena , Drug Information Services , Famotidine/chemistry , Nonprescription Drugs/chemistry , Chromatography, High Pressure Liquid , Humans , Hydrogen-Ion Concentration , Pharmacists , Professional Role , Self Medication , Solubility , Solutions , Time Factors , WaterABSTRACT
The current study was designed to prepare surface modified BC matrices loaded with model drugs selected on the basis of their aqueous solubility, i.e., poorly water soluble famotidine and highly water soluble tizanidine. Fourier transform infrared (FT-IR) spectroscopy, X-ray diffraction (XRD), scanning electron microscopy (SEM) and thermogravimetric analysis (TGA) confirmed the successful drug loading and thermal stability of the BC matrices. In-vitro dissolution studies using USP type-II dissolution apparatus showed that most of the drug was released in 0.5-3h from famotidine loaded matrices and in 0.25-0.5h from tizanidine loaded matrices. The chemical structure, concentration of the loaded drug, concentration of the surface modifier, and pre- and post-drug loading modifications altered the physicochemical properties of BC matrices, which in turn affected the drug release behavior. In general, surface modification of the BC matrices enhanced the drug release retardant properties in pre-modification drug loading. Surface modification was found to be effective for controlling the drug release properties of BC. Therefore, these modified BC matrices have the potential for applications in modified drug delivery systems.
Subject(s)
Cellulose/chemistry , Drug Carriers/chemistry , Gluconacetobacter xylinus/chemistry , Clonidine/analogs & derivatives , Clonidine/chemistry , Drug Liberation , Famotidine/chemistry , Kinetics , Solubility , Surface Properties , Water/chemistryABSTRACT
In this study, a novel resonance light scattering (RLS) sensor was synthesized using polyacrylonitrile nanofibers decorated with magnetic carbon dots (MCDs@NFs) nanocomposite and applied for famotidine (FMD) determination. The MCDs@NFs nanocomposite was synthesized by combining electrospinning and a simple one-step hydrothermal method. Different methods were applied in order to characterize the MCDs@NFs nanocomposite such as: scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FT-IR), Transmission electron microscopy (TEM), X-ray photoelectron spectroscopy (XPS), and X-ray diffraction (XRD). Light scattering properties of the synthesized nanocomposite in the presence or absence of FMD have been selected as the detection signal considering the fact that FMD addition increases the RLS intensities of the system. Thus, the prepared nanocomposite was employed as a RLS sensor to detect FMD. A linear response was observed under the optimal conditions in range of 0.15-50.0µmolL-1 with detection limit of 0.04µmolL-1. The MCDs@NFs nanocomposite was effectively capable in determining FMD in real samples and the results were close to those results obtained by reversed-phase HPLC method (RP-HPLC).